In general, use of a vascular closure device after transfemoral percutaneous coronary intervention (PCI) decreases the risk of vascular complications, according to a large registry study of real-world ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The FDA announced that it recently ...

Innovative Patient-Friendly Device Combines Safety of Extravascular Sealant and Security of Mechanical Closure to Provide Consistent Results “We are proud of the advantages Mynx Ace offers to femoral ...

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — While there is not yet definitive evidence that vascular closure devices produce better ...

BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...

Chicago, IL - A new vascular closure device with a bioabsorbable plug has shown impressive results in a pivotal multicenter trial, ECLIPSE. The device, named ExoSeal (Cordis), also has a unique ...

- Passive approximators segment, femoral access segment are set to lay claim to a sizeable share of the market under the product and access type category, respectively - Asia-Pacific (APAC) will ...

A head-to-head comparison of vascular closure devices defied expectations in the CHOICE-CLOSURE trial. For large-bore arterial access site closure after transfemoral transcatheter aortic valve ...

Earlier this week, Needham downgraded Haemonetics from “Buy” to “Hold,” pointing to intensifying competition in vascular closure devices from Abbott and Cordis and warning that this could weigh on the ...

Selbyville, Delaware, May 05, 2020 (GLOBE NEWSWIRE) -- Global large bore vascular closure devices market size is valued at US$508.5 million in 2020 and is projected to hit a valuation of US$848.3 ...